Today: 10 June 2026
Browse Category

NASDAQ:SCNI 24 April 2026

Scinai Stock Surges on $2.61 Million Private Placement as SCNI Bets on CDMO Expansion

Scinai Stock Surges on $2.61 Million Private Placement as SCNI Bets on CDMO Expansion

Scinai Immunotherapeutics shares soared 82% Friday after the company announced a $2.61 million private placement and warrant inducement to fund its contract drug-manufacturing and immunotherapy work. The financing includes the sale of 5.2 million ADSs at $0.48 each and new warrants, with closing expected around April 27. Scinai reported $1.6 million cash at year-end and a going-concern warning in its latest filing.
24 April 2026
·

Stock Market Today

  • UiPath Launches Coding Agents Platform, Gains UAE Cybersecurity Certification Amid Falling Shares
    June 10, 2026, 8:49 AM EDT. UiPath (NYSE:PATH) has introduced "UiPath for Coding Agents," enhancing automation deployment with better orchestration and governance. Additionally, it secured a key cybersecurity certification in the UAE, enabling the Automation Cloud's use by Tier 1 enterprises and government bodies. Despite these advances, PATH's stock trades near $10.75, down 32.3% year-to-date and 84.6% over five years. The developments boost UiPath's product capabilities and customer trust, critical for growth in software automation. Investors should watch for adoption rates of the new platform and potential UAE contracts that could impact future revenue. Currently, the stock trades 19% below analyst targets and is deemed undervalued by Simply Wall St, although momentum remains slightly negative.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
Go toTop